CFO4Life Group’s Plains GP Holdings PAGP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Buy
9,492
+153
+2% +$3.67K 0.03% 215
2026
Q1
$227K Buy
+9,339
New +$204K 0.03% 191
2025
Q2
Sell
-9,517
Closed -$203K 243
2025
Q1
$203K Sell
9,517
-837
-8% -$17.6K 0.03% 204
2024
Q4
$190K Buy
10,354
+173
+2% +$3.21K 0.03% 206
2024
Q3
$188K Buy
10,181
+168
+2% +$3.19K 0.03% 205
2024
Q2
$188K Buy
+10,013
New +$184K 0.04% 189
2023
Q3
Sell
-11,383
Closed -$169K 180
2023
Q2
$169K Buy
11,383
+166
+1% +$2.29K 0.04% 161
2023
Q1
$147K Buy
11,217
+165
+1% +$2.16K 0.03% 152
2022
Q4
$137K Buy
11,052
+137
+1% +$1.71K 0.03% 168
2022
Q3
$119K Buy
10,915
+151
+1% +$1.73K 0.03% 143
2022
Q2
$114K Buy
10,764
+155
+1% +$1.78K 0.03% 141
2022
Q1
$123K Buy
10,609
+121
+1% +$1.39K 0.03% 151
2021
Q4
$106K Buy
10,488
+125
+1% +$1.35K 0.02% 152
2021
Q3
$112K Buy
10,363
+275
+3% +$2.88K 0.03% 138
2021
Q2
$120K Buy
+10,088
New +$108K 0.03% 138
2021
Q1
Sell
-10,342
Closed -$87K 150
2020
Q4
$87K Buy
+10,342
New +$80.3K 0.03% 139

Other funds holding PAGP

CFO4Life Group's PAGP Position: Q2 2026 in Review

CFO4Life Group increased its Plains GP Holdings (PAGP) stake by 1.6% in Q2 2026, buying an estimated $3.67K and bringing the position to 9,492 shares worth $230K. The position accounts for 0.03% of the portfolio, ranked #215.

CFO4Life Group first reported a position in PAGP in Q4 2020 and has held it in 16 quarters since. 342 funds tracked by Wall St. Rank hold PAGP as of Q2 2026.

  • CFO4Life Group held 9,492 shares of Plains GP Holdings worth $230K as of Q2 2026.
  • CFO4Life Group bought 153 Plains GP Holdings shares in Q2 2026, an estimated $3.67K.
  • Plains GP Holdings made up 0.03% of CFO4Life Group's portfolio in Q2 2026, its #215 holding.
  • CFO4Life Group first reported a position in Plains GP Holdings in Q4 2020 and has held it in 16 quarters since.
  • 342 funds tracked by Wall St. Rank held Plains GP Holdings as of Q2 2026.

Based on CFO4Life Group's 13F filing for Q2 2026, filed 12 Aug 2026.